Financial Performance - Total revenues for Q3 2024 were 8,202,000,anincreaseof157,140,000 in Q3 2023[7] - Product revenues for the nine months ended September 30, 2024, reached 22,057,000,upfrom14,229,000 in the same period last year, representing a 55% increase[7] - The company reported a net loss of 36,763,000forQ32024,comparedtoanetincomeof30,931,000 in Q3 2023[7] - Operating expenses for Q3 2024 totaled 32,466,000,significantlyhigherthan12,946,000 in Q3 2023, reflecting a 150% increase[7] - For the nine months ended September 30, 2024, the net loss was 70,175,asignificantdecreasefromanetincomeof34,236 for the same period in 2023[10] - The company reported a net income of 30,931forthequarterendingJune30,2023,comparedtoanetlossof6,464 for the previous quarter[8] - The net loss for Q3 2024 was 36,763,000,comparedtoanetincomeof30,931,000 in Q3 2023[7] - The net loss for the nine months ended September 30, 2024, was 70.175million,comparedtoanetincomeof34.236 million for the same period in 2023[10] Cash and Assets - Cash and cash equivalents decreased to 56,396,000asofSeptember30,2024,downfrom75,502,000 at the end of 2023[6] - Total assets decreased to 399,555,000asofSeptember30,2024,comparedto461,834,000 at the end of 2023[6] - The company’s accumulated deficit increased to (24,605,000)asofSeptember30,2024,from45,570,000 at the end of 2023[6] - The total stockholders' equity decreased to 358,856,000asofSeptember30,2024,downfrom422,507,000 at the end of 2023[6] - The company reported cash and cash equivalents of 56.4millionasofSeptember30,2024,downfrom75.5 million as of December 31, 2023[18] - As of September 30, 2024, accounts receivable totaled 18.649million,withaprovisionforcreditlossesof730,000, resulting in net accounts receivable of 17.919million[25]−Thetotalfairvalueoffinancialassetswas97.09 million, with cash equivalents at 40.08millionandmarketablesecuritiesat56.99 million[55] Expenses and Impairments - Research and development expenses for the nine months ended September 30, 2024, were 15,338,000,slightlydownfrom15,398,000 in the same period last year[7] - The company reported an impairment of assets amounting to 15,170,000inQ32024[7]−Thecompanyrecordedanimpairmentlossof12.3 million related to capitalized costs for the Origin 2 project, which were deemed not recoverable as of September 30, 2024[33] - Depreciation and amortization expense for the nine months ended September 30, 2024, totaled 7.9million,comparedto1.0 million for the same period in 2023[65] Stock and Equity - The weighted-average common shares outstanding for Q3 2024 were 143,387,618, compared to 139,806,045 in Q3 2023[7] - The Company has a total of 24,149,960 Public Warrants and 11,326,667 Private Placement Warrants outstanding as of September 30, 2024, with an exercise price of 11.50pershare[34]−TheCompanyhasnotdeclaredcommonstockdividendsanddoesnotanticipatedeclaringanyintheforeseeablefuture[43]−TheCompanyhaspotentialdilutivesecuritiestotaling25millionearnoutsharesthatwereexcludedfromthedilutednetlosspersharecalculationduetoperformanceconditionsnotbeingmet[95]−TheCompanyrecordedatotalworkforcereductionchargeof0.6 million in September 2024, which included 0.5millionincashexpendituresforemployeeseparationcosts[86]BusinessOperationsandDevelopments−OriginMaterialsachievedmechanicalcompletionofitsfirstfuranicsmanufacturingplantinOntario,Canada,whichiscurrentlyoperatingondemandwithreducedstaffing[11]−ThecompanyannounceditsPETcapsandclosuresbusinessinAugust2023,withmassproductionpartnershipsestablishedinEuropeandNorthAmerica[11]−ThefirstPETclosuremanufacturingsystemsuccessfullycompleteditsFactoryAcceptanceTestinSeptember2024[11]−Thecompanyisexploringvariousplantdesignsandpotentialsitesforscalingupbiomassconversiontechnology,withtimelinesdependingonpartneragreements[11]−Thecompanymaintainsanallowanceforcreditlossesbasedonhistoricallosspatternsandevaluatespotentialrisksassociatedwithaccountsreceivable[17]LegalandRegulatoryMatters−TheCompanyisfacinglegalproceedingsrelatedtoasecuritiesclassactioncomplaintfiledbyshareholders,allegingviolationsoffederalsecuritieslaws[92]TaxandAccounting−TheCompanyrecordedanincometaxprovisionof0.2 million and $0.4 million during the three and nine months ended September 30, 2024, respectively[87] - The Company has a full valuation allowance on its net deferred tax assets in the U.S. due to operating losses since inception[87] - The Company does not expect the adoption of new accounting guidance to have a material impact on its consolidated financial statements, aside from additional disclosures[52]